Tin tức & Cập nhật
Xem bài viết Tiêu hóa
Xem
Chỉ hiển thị Multimedia

GLP-1 RAs reduce depression, substance use in young patients with obesity, MASLD
17 Jun 2025
bởiStephen Padilla
In paediatric patients with obesity and metabolic dysfunction-associated steatotic liver disease (MASLD), treatment with GLP-1 receptor agonists (RAs) results in a decrease in depression and substance use, as shown in a study presented at ESPGHAN 2025.
17 Jun 2025







